Impact of blinatumomab on patient outcomes in relapsed/refractory acute lymphoblastic leukemia: evidence to date

Hathaway L, Sen JM, Keng M

Patient Related Outcome Measures 2018, 9:329-337

Published Date: 2 October 2018